Detail page

Knowledge Web

Person

Elisabeth Bendstrup

Ärztin

Name	Elisabeth Bendstrup
Place	Sonstiges Ausland / Unbekanntes Land
Academic degree	MD, PhD
Profession	Ärztin (characteristic profession)
Further information	Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus
Record type	Person
GND-Identifier	1189169967
Record ID	1189169967
Involved in show all Study protocol: COPD–eosinophil-guided reduction of inhaled corticosteroids (COPERNICOS) : A randomized, double-blinded, multicenter, four-arm intervention clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid therapy and prophylactic low dose Azithromycin therapy in patients with severe or very severe chronic obstructive pulmonary disease (COPD) Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey Das Muster der gewöhnlichen interstitiellen Pneumonie bei rheumatischen Autoimmunerkrankungen Validity and reliability of measurement of peripheral oxygen saturation during the 6-Minute Walk Test in patients with systemic sclerosis The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial Fatigue in Patients with Sarcoidosis in Denmark Association between Parenchymal B-Cell Follicles and CT-Proven Enlarged Mediastinal Lymph Nodes in Patients with Pulmonary Fibrosis Clusters of comorbidities in fibrotic hypersensitivity pneumonitis Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis Comorbidities in unclassifiable interstitial lung disease Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis Validation of a derived version of the IPF-specific Saint George’s Respiratory Questionnaire Global incidence and prevalence of idiopathic pulmonary fibrosis Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities Real-World Data on Bleeding Risk and Anticoagulation in Patients with IPF Treated with Antifibrotics The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease – a randomised placebo-controlled trial Early referral to palliative care in IPF – pitfalls and opportunities in clinical trials Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease Validation of the King’s Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis Validation of the IPF-specific version of St. George’s Respiratory Questionnaire Risk factors for diagnostic delay in idiopathic pulmonary fibrosis Rheumatoid Arthritis-Associated Interstitial Lung Disease: Clinical Characteristics and Predictors of Mortality Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study Cryobiopsies are diagnostic in Pleuroparenchymal and Airway-centered Fibroelastosis Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis Lung Ultrasound – A Novel Diagnostic Tool To Phenotype Chronic Lung Allograft Dysfunction? Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Elisabeth Bendstrup

Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey

Das Muster der gewöhnlichen interstitiellen Pneumonie bei rheumatischen Autoimmunerkrankungen

Validity and reliability of measurement of peripheral oxygen saturation during the 6-Minute Walk Test in patients with systemic sclerosis

The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases

New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review

Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial

Fatigue in Patients with Sarcoidosis in Denmark

Association between Parenchymal B-Cell Follicles and CT-Proven Enlarged Mediastinal Lymph Nodes in Patients with Pulmonary Fibrosis

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis

Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis

Comorbidities in unclassifiable interstitial lung disease

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis

Validation of a derived version of the IPF-specific Saint George’s Respiratory Questionnaire

Global incidence and prevalence of idiopathic pulmonary fibrosis

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities

Real-World Data on Bleeding Risk and Anticoagulation in Patients with IPF Treated with Antifibrotics

The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease

Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease – a randomised placebo-controlled trial

Early referral to palliative care in IPF – pitfalls and opportunities in clinical trials

Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis

Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease

Validation of the King’s Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis

Validation of the IPF-specific version of St. George’s Respiratory Questionnaire

Risk factors for diagnostic delay in idiopathic pulmonary fibrosis

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Clinical Characteristics and Predictors of Mortality

Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study

Cryobiopsies are diagnostic in Pleuroparenchymal and Airway-centered Fibroelastosis

Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis

Lung Ultrasound – A Novel Diagnostic Tool To Phenotype Chronic Lung Allograft Dysfunction?

Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events

Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events